Skip to content

Clinical trials

Lung Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Poland Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20102
20111
20121
20133
20146
20153
20162
20171
20182
20194
20202
20222
20232
20243
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting11
Active, not recruiting5
Terminated3
Enrolling by invitation2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca16
Pfizer3
Eli Lilly and Company2
Novartis Pharmaceuticals2
United Therapeutics2
Upstream Bio Inc.2
Checkpoint Therapeutics, Inc.1
Daiichi Sankyo1
Grifols Therapeutics LLC1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases44
Respiratory Tract Diseases24
Asthma14
Lung Diseases, Obstructive14
Bronchial Diseases13
Carcinoma, Non-Small-Cell Lung10
Pulmonary Disease, Chronic Obstructive10
Lung Neoplasms9
Neoplasms8
Thoracic Neoplasms6

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.